Literature DB >> 9013873

Vav is associated with signal transducing molecules gp130, Grb2 and Erk2, and is tyrosine phosphorylated in response to interleukin-6.

I S Lee1, Y Liu, M Narazaki, M Hibi, T Kishimoto, T Taga.   

Abstract

Vav is a hematopoietic cell-specific proto-oncogene. We show that interleukin-6 (IL-6) induces transient tyrosine phosphorylation of Vav in a human myeloma cell line, U266. A membrane-distal part of the cytoplasmic region of gp130 is critical for association between Vav and gp130, and the IL-6-induced tyrosine phosphorylation of Vav. Mitogen-activated protein kinase (MAPK) (p42MAPK or extracellular signal-regulated kinase 2 (Erk2)) is coprecipitated with Vav. MAPK activity in the anti-Vav immunoprecipitates is upregulated by IL-6 stimulation. Furthermore Vav is associated with Grb2 which is known as an adapter protein leading to Ras activation. The results imply that Vav may link gp130 activation to downstream MAPK activation in hematopoietic cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9013873     DOI: 10.1016/s0014-5793(96)01456-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  Regulatory and signaling properties of the Vav family.

Authors:  X R Bustelo
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  Identification of molecular vulnerabilities in human multiple myeloma cells by RNA interference lethality screening of the druggable genome.

Authors:  Rodger E Tiedemann; Yuan Xao Zhu; Jessica Schmidt; Chang Xin Shi; Chris Sereduk; Hongwei Yin; Spyro Mousses; A Keith Stewart
Journal:  Cancer Res       Date:  2011-12-06       Impact factor: 12.701

3.  Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation.

Authors:  L Zeng; P Sachdev; L Yan; J L Chan; T Trenkle; M McClelland; J Welsh; L H Wang
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 4.  Multiple myeloma: increasing evidence for a multistep transformation process.

Authors:  M Hallek; P L Bergsagel; K C Anderson
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

5.  Extracellular regulated kinase (ERK) interaction with actin and the calponin homology (CH) domain of actin-binding proteins.

Authors:  B D Leinweber; P C Leavis; Z Grabarek; C L Wang; K G Morgan
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

6.  Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components.

Authors:  J J Schuringa; L J Jonk; W H Dokter; E Vellenga; W Kruijer
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

Review 7.  Breast Cancer and Prolactin - New Mechanisms and Models.

Authors:  Charles V Clevenger; Hallgeir Rui
Journal:  Endocrinology       Date:  2022-10-01       Impact factor: 5.051

8.  Lipopolysaccharide up-regulates IL-6R alpha expression in cultured leptomeningeal cells via activation of ERK1/2 pathway.

Authors:  Ting Wang; Bai-Ren Wang; Hua-Zhou Zhao; Fang Kuang; Juan Fan; Xiao-Li Duan; Gong Ju
Journal:  Neurochem Res       Date:  2008-03-21       Impact factor: 3.996

9.  Ligand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancer.

Authors:  Leah S Lyons; Shuyun Rao; Wayne Balkan; Joanne Faysal; Carol A Maiorino; Kerry L Burnstein
Journal:  Mol Endocrinol       Date:  2007-12-13

10.  Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling.

Authors:  R Turk; E Sterrenburg; E J de Meijer; G-J B van Ommen; J T den Dunnen; P A C 't Hoen
Journal:  BMC Genomics       Date:  2005-07-13       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.